Circular RNA TRAPPC6B inhibits intracellular Mycobacterium tuberculosis growth while inducing autophagy in macrophages by targeting microRNA-874-3p
- PMID: 33708385
- PMCID: PMC7890665
- DOI: 10.1002/cti2.1254
Circular RNA TRAPPC6B inhibits intracellular Mycobacterium tuberculosis growth while inducing autophagy in macrophages by targeting microRNA-874-3p
Abstract
Objectives: Genetic and epigenetic mechanisms regulate antimicrobial immunity against Mycobacterium tuberculosis (Mtb) infection.
Methods: The present study assessed circular RNA TRAPPC6B (circTRAPPC6B) for antimicrobial immune functions and defined mechanisms wherein circTRAPPC6B regulates Mtb growth, autophagy and microRNA in macrophages.
Results: The Mtb infection of monocytes/macrophages resulted in a significantly decreased level of circTRAPPC6B that inhibited intracellular Mtb growth in macrophages. Conversely, circTRAPPC6B expression enhanced autophagy or autophagy-associated protein LC3-II production in Mtb-infected macrophages. circTRAPPC6B-enhanced autophagy aggregation or sequestration was also observed in fluorescence in situ hybridisation (FISH) analysis and confocal imaging. Mechanistically, circTRAPPC6B targets an inhibiting element miR-874-3p, as shown by bioinformatics, dual-luciferase reporter gene analysis and pull-down assay, respectively. Notably, miR-874-3p prohibited autophagy via suppressing autophagy protein ATG16L1 by binding to its 3'-untranslated region (UTR) in Mtb-infected macrophages and thus promoting intracellular Mtb growth. Concurrently, circTRAPPC6B enhanced autophagy in Mtb-infected macrophages by blocking the ability of miR-874-3p to inhibit ATG16L1. Thus, circTRAPPC6B antagonises the ability of miR-874-3p to suppress ATG16L1 expression and activate and enhance autophagy sequestration to restrict Mtb growth in macrophages.
Conclusion: The current findings suggested that both circTRAPPC6B and miR-874-3p mechanisms can be explored as potential therapeutics against Mtb infection.
Keywords: Mycobacterium tuberculosis; autophagy; circTRAPPC6B; macrophage; miR‐874‐3p.
© 2021 The Authors. Clinical & Translational Immunology published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology, Inc.
Conflict of interest statement
The authors declare no conflict of interest.
Figures








Similar articles
-
Circular RNA circTRAPPC6B Enhances IL-6 and IL-1β Expression and Repolarizes Mycobacteria Induced Macrophages from M2- to M1-Like Phenotype by Targeting miR-892c-3p.J Interferon Cytokine Res. 2023 Jun;43(6):269-279. doi: 10.1089/jir.2023.0007. J Interferon Cytokine Res. 2023. PMID: 37319356
-
MicroRNA-142-3p inhibits autophagy and promotes intracellular survival of Mycobacterium tuberculosis by targeting ATG16L1 and ATG4c.Int Immunopharmacol. 2021 Dec;101(Pt A):108202. doi: 10.1016/j.intimp.2021.108202. Epub 2021 Oct 4. Int Immunopharmacol. 2021. PMID: 34619495
-
Mmu-miR-25-3p promotes macrophage autophagy by targeting DUSP10 to reduce mycobacteria survival.Front Cell Infect Microbiol. 2023 May 15;13:1120570. doi: 10.3389/fcimb.2023.1120570. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37256106 Free PMC article.
-
MicroRNA-144-3p Inhibits Host Lipid Catabolism and Autophagy by Targeting PPARα and ABCA1 During Mycobacterium Tuberculosis Infection.ACS Infect Dis. 2024 May 10;10(5):1654-1663. doi: 10.1021/acsinfecdis.3c00731. Epub 2024 Apr 5. ACS Infect Dis. 2024. PMID: 38578697
-
The Macrophage Response to Mycobacterium tuberculosis and Opportunities for Autophagy Inducing Nanomedicines for Tuberculosis Therapy.Front Cell Infect Microbiol. 2021 Feb 8;10:618414. doi: 10.3389/fcimb.2020.618414. eCollection 2020. Front Cell Infect Microbiol. 2021. PMID: 33628745 Free PMC article. Review.
Cited by
-
Engineering zinc oxide hybrid selenium nanoparticles for synergetic anti-tuberculosis treatment by combining Mycobacterium tuberculosis killings and host cell immunological inhibition.Front Cell Infect Microbiol. 2023 Jan 26;12:1074533. doi: 10.3389/fcimb.2022.1074533. eCollection 2022. Front Cell Infect Microbiol. 2023. PMID: 36776549 Free PMC article.
-
Macrophage targeted iron oxide nanodecoys augment innate immunological and drug killings for more effective Mycobacterium Tuberculosis clearance.J Nanobiotechnology. 2023 Oct 10;21(1):369. doi: 10.1186/s12951-023-02103-x. J Nanobiotechnology. 2023. PMID: 37817142 Free PMC article.
-
The role of circular RNA in immune response to tuberculosis and its potential as a biomarker and therapeutic target.Front Immunol. 2025 Apr 16;16:1542686. doi: 10.3389/fimmu.2025.1542686. eCollection 2025. Front Immunol. 2025. PMID: 40308608 Free PMC article. Review.
-
Past, Present and Future: The Relationship Between Circular RNA and Immunity.Front Immunol. 2022 May 25;13:894707. doi: 10.3389/fimmu.2022.894707. eCollection 2022. Front Immunol. 2022. PMID: 35693804 Free PMC article. Review.
-
Identification of functional circRNAs regulating ovarian follicle development in goats.BMC Genomics. 2024 Sep 28;25(1):893. doi: 10.1186/s12864-024-10834-w. BMC Genomics. 2024. PMID: 39342142 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Other Literature Sources